Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-03-30 | 2023-08-23 | 188427 |
APO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-06-09 | 2023-07-27 | 194568 |
APO-EXEMESTANE | 25MG | TABLET | Resolved | 2017-03-10 | 2019-06-12 | 314 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 318 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-25 | 655 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-04-04 | 2017-04-25 | 5366 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-05-04 | 2017-07-18 | 8862 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-05-16 | 2017-07-18 | 10400 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2019-08-14 | 2019-10-07 | 91535 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2018-02-01 | 2018-04-23 | 37956 |
APO-EZETIMIBE | 10MG | TABLET | Actual shortage | 2023-12-08 | 2024-01-19 | 212961 |
APO-EZETIMIBE | 10MG | TABLET | Actual shortage | 2024-01-05 | 2024-01-19 | 215247 |
APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2023-12-08 | 2024-01-19 | 212955 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2017-09-26 | 2018-01-18 | 23553 |
APO-FAMCICLOVIR | 125MG | TABLET | Resolved | 2017-10-23 | 2018-01-19 | 26572 |
APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2017-03-12 | 2017-04-17 | 719 |
APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2020-08-12 | 2020-12-29 | 122062 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2020-08-19 | 2021-01-11 | 122480 |
APO-FAMCICLOVIR | 125MG | TABLET | Resolved | 2020-10-07 | 2020-12-29 | 125803 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2020-02-05 | 2020-02-25 | 105333 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2018-10-25 | 2018-10-25 | 65585 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |
ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-09-12 | 40841 |
ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-10-25 | 40844 |
APO ACETAMINOPHEN TAB 325MG | 325MG | TABLET | Discontinued | 2018-10-11 | 2018-10-11 | 63845 |
APO ACETAMINOPHEN TAB 500MG | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
APO ACETAMINOPHEN TAB 500MG | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-08-08 | 70807 |
APO ACETAMINOPHEN TAB 500MG | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
APO CARBAMAZEPINE TAB 200MG | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
APO CHLORPROPAMIDE TAB 100MG | 100MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1196 |
APO CHLORPROPAMIDE TAB 250MG | 250 mg | tablet | Discontinued | 2017-03-13 | 2018-02-05 | 1235 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60435 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |